輸入代號或公司名稱後按 Enter
1762

中化生

+0.15 (+0.45%)最後更新 2026-09-16
台灣 · 上市 · 生技醫療業
33.6524成交張數本益比0.80股價淨值比0.00%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入2025805年增 -40.3%
毛利率2025-1.1%最新一期
營業利益率2025-39.7%最新一期
每股盈餘2025-4.39年增 -562.1%
會計項目走勢2016201720182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計65.4%65.1%65.5%59.5%55.5%50.9%54.6%63.7%70.7%101.1%
營業毛利(毛損)34.6%34.9%34.5%40.5%44.5%49.1%45.4%36.3%29.3%-1.1%
營業毛利(毛損)淨額34.6%34.9%34.5%40.5%44.5%49.1%45.4%36.3%29.3%-1.1%
營業費用合計26.4%28.2%31.4%30.0%27.1%26.4%23.5%22.8%28.8%38.6%
營業利益(損失)8.2%6.7%3.0%10.5%17.4%22.7%21.9%13.5%0.5%-39.7%
稅前淨利(淨損)7.8%9.4%23.6%12.4%42.1%25.7%27.6%16.0%4.2%-31.8%
所得稅費用(利益)合計2.7%2.0%0.6%2.3%7.7%5.0%5.5%3.3%0.3%-1.5%
繼續營業單位本期淨利(淨損)5.0%7.4%23.0%10.1%34.5%20.7%22.0%12.7%3.9%-30.3%
本期淨利(淨損)5.0%7.4%23.0%10.1%34.5%20.7%22.0%12.7%3.9%-30.3%
本期綜合損益總額4.3%7.6%19.8%10.8%35.4%26.5%18.9%12.4%5.1%-29.4%
母公司業主(淨利∕損)5.0%7.3%23.0%10.1%34.5%20.7%22.0%12.7%3.9%-30.3%
基本每股盈餘0.1%0.1%0.3%0.1%0.4%0.3%0.3%0.2%0.1%-0.5%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。